215 results
Page 7 of 11
8-K
EX-99.1
9zxj99r0of
3 Aug 20
VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:10am
S-3ASR
EX-1.2
jxgn7x8
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-99.2
hmcydqcw 788jd
22 Jun 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
57cn8jr
15 May 20
VBI Vaccines Announces Upcoming Poster Presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR Virtual Annual Meeting
12:39pm
8-K
EX-99.1
nbbst6fg4ansz 4scxw
6 May 20
Results of Operations and Financial Condition
8:35am
8-K
EX-1.1
5klf140nm83h6utm3dpq
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
424B5
o0kg14
21 Apr 20
Prospectus supplement for primary offering
4:18pm
8-K
EX-99.1
xvc51n
5 Mar 20
VBI Vaccines Provides Corporate Update, Outlook for 2020, and Year-End 2019 Financial Results
12:40pm
8-K
EX-99.1
2zw2kbaqpzt
3 Mar 20
Other Events
10:00am
8-K
EX-99.1
4esba
2 Mar 20
Other Events
11:14am
8-K
EX-99.1
fpwssz91
10 Jan 20
VBI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac® Meets Primary and Secondary Endpoints
3:23pm
8-K
EX-99.1
yyizd7y5 6kh4ap7g
22 Nov 19
Other Events
8:11am
8-K
EX-99.1
x4efu2
14 Nov 19
Other Events
4:54pm
8-K
EX-99.1
gn6rxpwps6
12 Nov 19
VBI Vaccines to Present Initial Phase 1/2a Part B Data of VBI-1901 at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
6:15am
8-K
EX-99.1
vu87sahyetyikb9aegpi
6 Nov 19
VBI Vaccines Announces Third Quarter 2019 Financial Results and Provides Corporate Update
8:51am